Compass Therapeutics, Inc.
CMPXBiotechnology
$0.76−0.54%As of Oct 29vs prior close
- Market cap
- $136.2M
- P/E (TTM)
- –
- From 52W high
- −88.70%
- EPS (YE25)
- -$0.42
- Revenue (YE25)
- $0
- Dividend yield
- 0.00%
Nomior Score
30
Steady ProfileBottom 15% of the scored universe
Growth—
Quality50
Value40
Momentum20
Resilience36
Growth
$0revenue, YE25
YE23 $0YE25 $0
Connections
Revenue to profitYE24
The operating loss was 6662% of revenue.
Who owns it
2funds